"Obesity stigma is rising due to new weight-loss drugs" - Prof. Donal O'Shea
Brendan O'Connor
00:00
Might GLP‑1 drugs affect Alzheimer’s, Parkinson’s, or cancer?
Donal outlines emerging research suggesting neuroprotection and potential oncologic roles, citing early promising studies like retatratide.
Play episode from 13:21
Transcript
